Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von StockNews.com 

Tenet Healthcare diskutieren

Tenet Healthcare

WKN: A1J5US / Symbol: THC / Name: Tenet Healthcare / Aktie / Anbieter & Dienstleistungen / Mid Cap /

169,00 €
-0,59 %

Einschätzung Buy
Rendite (%) 40,83 %
Kursziel 168,05
Veränderung
Endet am 06.01.26

Tenet Healthcare Co. (NYSE: THC) had its price target lowered by analysts at Truist Financial Co. from $190.00 to $175.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 35,20 %
Kursziel 178,30
Veränderung
Endet am 07.01.26

Tenet Healthcare Co. (NYSE: THC) had its price target lowered by analysts at KeyCorp from $200.00 to $185.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 32,03 %
Kursziel 154,88
Veränderung
Endet am 13.02.26

Tenet Healthcare Co. (NYSE: THC) had its price target lowered by analysts at Barclays PLC from $190.00 to $161.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 32,03 %
Kursziel 169,60
Veränderung
Endet am 13.02.26

Tenet Healthcare Co. (NYSE: THC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $177.00 price target on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 35,20 %
Kursziel 166,76
Veränderung
Endet am 26.02.26

Tenet Healthcare Co. (NYSE: THC) is now covered by analysts at TD Cowen. They set a "buy" rating and a $175.00 price target on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 36,29 %
Kursziel 152,89
Veränderung
Endet am 26.03.26

Tenet Healthcare Co. (NYSE: THC) is now covered by analysts at Morgan Stanley. They set an "overweight" rating and a $165.00 price target on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 48,25 %
Kursziel 149,57
Veränderung
Endet am 09.04.26

Tenet Healthcare Co. (NYSE: THC) is now covered by analysts at Guggenheim. They set a "buy" rating and a $165.00 price target on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 37,40 %
Kursziel 202,29
Veränderung
Endet am 30.04.26

Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at UBS Group AG from $217.00 to $230.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 34,13 %
Kursziel 166,23
Veränderung
Endet am 30.04.26

Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Royal Bank of Canada from $183.00 to $189.00. They now have an "outperform" rating on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 27,07 %
Kursziel 154,39
Veränderung
Endet am 05.05.26

Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Morgan Stanley from $165.00 to $175.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 21,58 %
Kursziel 169,25
Veränderung
Endet am 12.05.26

Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Truist Financial Co. from $175.00 to $190.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 19,01 %
Kursziel 160,87
Veränderung
Endet am 14.05.26

Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Bank of America Co. from $165.00 to $180.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 12,67 %
Kursziel 173,30
Veränderung
Endet am 29.05.26

Tenet Healthcare Co. (NYSE: THC) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $195.00 price target on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 13,42 %
Kursziel 189,09
Veränderung
Endet am 02.06.26

Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Barclays PLC from $171.00 to $215.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat

Tenet Healthcare Co. (NYSE: THC) was upgraded by analysts at Stephens to a "strong-buy" rating.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 16,55 %
Kursziel 183,90
Veränderung
Endet am 09.06.26

Tenet Healthcare Co. (NYSE: THC) had its price target raised by analysts at Morgan Stanley from $175.00 to $210.00. They now have an "overweight" rating on the stock.
Ratings data for THC provided by MarketBeat

Tenet Healthcare Co. (NYSE: THC) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 14,19 %
Kursziel 166,16
Veränderung
Endet am 11.07.26

Tenet Healthcare Corporation (NYSE: THC) had its price target raised by analysts at Mizuho from $184.00 to $194.00. They now have an "outperform" rating on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 13,42 %
Kursziel 176,55
Veränderung
Endet am 16.07.26

Tenet Healthcare Corporation (NYSE: THC) had its price target raised by analysts at Truist Financial Corporation from $190.00 to $205.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat

Einschätzung Buy
Rendite (%) 25,19 %
Kursziel 160,14
Veränderung
Endet am 23.07.26

Tenet Healthcare Corporation (NYSE: THC) had its price target raised by analysts at Guggenheim from $180.00 to $188.00. They now have a "buy" rating on the stock.
Ratings data for THC provided by MarketBeat